Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences

Prime Therapeutics, Inc.
(NASDAQ: FPRX), a clinical-stage
biotechnology company focused on discovering and developing innovative
immuno-oncology protein therapeutics today announced that Aron
Knickerbocker, Chief Executive Officer, is scheduled to present at the
following two investor conferences:

  • The Jefferies Healthcare Conference, on Thursday, June 6th
    at 9:30am ET / 6:30am PT
  • The 40th Annual Goldman Sachs Global Healthcare Conference
    on Wednesday, June 12th at 1:00pm ET / 10:00am PT

The presentations will be webcast and may be accessed at the “Events &
Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm.
Five Prime will maintain an archived replay of the webcast on its
website for 30 days after the conference.

About Five Prime

Five Prime Therapeutics, Inc. discovers and develops innovative protein
therapeutics to improve the lives of patients with serious diseases.
Five Prime’s product candidates have innovative mechanisms of action and
address patient populations in need of better therapies. The company
focuses on researching and developing immuno-oncology and targeted
cancer therapies paired with companion diagnostics to identify patients
who are most likely to benefit from treatment with Five Prime’s product
candidates. Five Prime has entered into strategic collaborations with
leading global pharmaceutical companies and has promising product
candidates in clinical and preclinical development. For more
information, please visit www.fiveprime.com or
follow us on LinkedInTwitter and Facebook.

Source: Five Prime Therapeutics, Inc.


Media and Investor Contact
Martin Forrest
VP, Investor
Relations & Corporate Communications
Five Prime Therapeutics,
[email protected]

Read the full article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.